Latest filing published 27 Sept 2024 for Hiscox Ltd, €5,227.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 13 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +27.1%Entry £10.82 · Close at T+365 £13.75
- +15.4%Entry £9.38 · Close at T+365 £10.82
- +1.0%Entry £11.02 · Close at T+365 £11.13
- -43.7%Entry £15.63 · Close at T+365 £8.80
- -11.8%Entry £15.85 · Close at T+365 £13.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anne MacDonald: trading record in brief
Anne MacDonald discloses dealings in Hiscox Ltd to RNS (LSE). We count 16 filings; the first trade dates from 14 December 2016 and the latest from 24 September 2024.
Every open-market trade on record is a purchase: 14 purchases worth €312k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. Since January 2024: 1 purchase and no sales on the market.
Half of the purchases are above €26k and half below. 11 out of 13 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 13 purchases show a median change of +2.7%, with the price up in 69% of them. These figures describe past trades and do not predict future prices.
Most recently, on 27 September 2024, the filings show an open-market purchase worth €5,227 in Hiscox Ltd. Filings reach the RNS (LSE) feed a median of 1 day after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Anne MacDonald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 368 shares@ £11.8426.4% of flowLondon Stock Exchange - XLONISIN BMG4593F1389RNS:5368058-0Canonical exit: 23 Dec 2024 (T+90)
- 463 shares@ £9.6626.0% of flowLondon Stock Exchange - XLONISIN BMG4593F1389RNS:4917428-0Canonical exit: 25 Dec 2023 (T+90)
- 689 shares@ £11.6847.6% of flowLondon Stock Exchange - XLONISIN BMG4593F1389RNS:4801219Canonical exit: 11 Sept 2023 (T+90)
- 1,508 shares@ £16.510954.1% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20191001163927_14249803_20200326185156382_36395-1Canonical exit: 29 Dec 2019 (T+90)
- 227 shares@ £15.907.8% of flowOutside a trading venueISIN BMG4593F1389FCA-NSM:LSE20190913171647_14226795_20200326185204356_23261-1
- 414 shares@ £16.435.6% of flowOutside a trading venueISIN BMG4593F1389FCA-NSM:LSE20190618162227_14115574_20200326185129433_14441-1
- 1,502 shares@ £15.575XLONISIN BMG4593F1389FCA-NSM:LSE20190401144421_14023955_20200326185045297_25761-0Canonical exit: 27 Jun 2019 (T+90)
- 1,525 shares@ £16.015619.7% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20181214172023_13905066_20200330111408470_14288-2Canonical exit: 14 Mar 2019 (T+90)
- 1,424 shares@ £16.50338.9% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20181002141714_13813507_20200330111443776_26123-1Canonical exit: 27 Dec 2018 (T+90)
- 1,518 shares@ £15.036216.0% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20180614165833_13680528_20200330111423852_14548Canonical exit: 12 Sept 2018 (T+90)
- 1,507 shares@ £14.4511.4% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20180403134225_13589762_20200330111354912_24712-1Canonical exit: 27 Jun 2018 (T+90)
- 1,574 shares@ £13.90279.2% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20171214164922_13466326_20200330131507963_11930-1Canonical exit: 14 Mar 2018 (T+90)
- 1,764 shares@ £12.804111.8% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20170929151415_13381026_20200330131541219_21844-2Canonical exit: 28 Dec 2017 (T+90)
- 1,848 shares@ £12.484512.1% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20170614155700_13260686_20200330131522370_11551-2Canonical exit: 12 Sept 2017 (T+90)
- 2,150 shares@ £11.024710.3% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20170330162043_13177705_20200330131526808_24914-2Canonical exit: 28 Jun 2017 (T+90)
- 2,309 shares@ £10.035112.7% of flowXLONISIN BMG4593F1389FCA-NSM:LSE20161215170447_013069002_20200330143549225_11841-2Canonical exit: 14 Mar 2017 (T+90)
16 of 16 declarations